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Objective: Enzyme-linked immunosorbent assays (ELISAs) are widely used to quantify 
immunoglobulin levels induced by infection or vaccination. Compared to conventional 
manual assays, automated ELISA systems offer more accurate and reproducible results, faster 
turnaround times and cost effectiveness due to the use of multianalyte reagents.
Design: The VaccZyme™ Human Anti-Haemophilus influenzae type B (Hib) kit (MK016) from 
The Binding Site Company was optimised to be used on an automated BioRad PhDTM system 
in the Immunology Laboratory (National Health Laboratory Service) in Tygerberg, South 
Africa.
Methods: An automated ELISA system that uses individual well incubation was compared to 
a manual method that uses whole-plate incubation. 
Results: Results were calculated from calibration curves constructed with each assay. Marked 
differences in calibration curves were observed for the two methods. The automated method 
produced lower-than-recommended optical density values and resulted in invalid calibration 
curves and diagnostic results. A comparison of the individual steps of the two methods 
showed a difference of 10 minutes per incubation cycle. All incubation steps of the automated 
method were subsequently increased from 30 minutes to 40 minutes. Several comparative 
assays were performed according to the amended protocol and all calibration curves obtained 
were valid. Calibrators and controls were also included as samples in different positions and 
orders on the plate and all results were valid.
Conclusion: Proper validation is vital before converting manual ELISA assays to automated 
or semi-automated methods.
© 2012. The Authors.
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Introduction
Quantitative analytical methods have advanced significantly since the development of the 
enzyme immunoassay (EIA) and enzyme-linked immunosorbent assay (ELISA) in 1971 by the 
groups of Perlmann and Engvall, and Schuurs and Van Weemen, respectively.1-3 Before this, the 
only method for performing immunoassays was the radioimmunoassay (RIA), which was first 
described by Yalow and  Berson in 1960.4
However, the RIA had several shortcomings, for example the potential health threat of radioactivity, 
short half-lives of radioisotopes, cumbersome radioactive waste disposal, expensive counting 
equipment, etc.3,5,6 An important shift from radioisotope-labelled liquid-phase assays to solid-
phase assays occurred in 1968. Miles and Hales7 developed an immuno-radiometric technique, 
which used radioactively labelled antibodies instead of labelled antigens for measuring insulin in 
human plasma. Plastic tubes were subsequently coated with the antigen or antibody to create a 
solid-phase or immunosorbent platform.8
Modern commercial ELISA/EIA kits use 96-well microtitre plates, where either an antigen or an 
antibody is noncovalently bound to a solid-phase support. These methods are widely employed by 
laboratories and manufacturing companies for microbiological, virological and other serological 
diagnostic tests, validation of assays and general quality control. Although automated pipetting 
devices have been used for more than two decades, the high cost associated with the technique 
remains a major limiting factor in developing countries and smaller laboratories.3
Materials and methods
The Immunology Unit of the National Health Laboratory Service (NHLS) in Tygerberg, South 
Africa, uses ELISAs for serological quantification of antibody levels. Before installation of the 
BioRad PhD™ system, all assays had been performed manually. The system performs sample 
dilution, dispenses patient samples and reagents into the microplate, and performs temperature-
specific incubation and washing according to pre-defined protocols.
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Automation of the MK016 enzyme-linked 
immunosorbent assay
The 96-well microtitre plate included in the VaccZyme™ 
Human Anti-Haemophilus influenzae type B (Hib) kit (MK016) 
from The Binding Site Company (Birmingham, United 
Kingdom) is precoated with the Hib capsular polysaccharide 
antigen conjugated to human serum albumin. In addition 
to controls and other reagents, the kit also contains five 
calibrators (0.1 mg/L – 9.0 mg/L) to construct a five-point 
calibration curve. Concentration (logarithmic scale) is 
plotted against optical density (linear scale) to produce 
the calibration curve. The quantification range for anti-Hib 
antibody concentration is 0.11 mg/L – 9.0 mg/L.9
Prediluted samples and controls were pipetted into the 
plate and incubated for 30 minutes. Unbound proteins were 
removed by a wash step before addition of conjugate (purified 
peroxidase-labelled rabbit anti-human g-chain-specific 
immunoglobulin G). After a further 30 minutes of incubation, 
another wash step was applied to remove all excess conjugate. 
Substrate (3.3’,5.5’ tetramethylbenzidine) was then added, 
which induced a colour change (from the characteristic 
serum colour to blue) over 30 minutes. Phosphoric acid was 
then added to stop colour development. The optical density 
(OD) was measured spectrophotometrically at 450 nm 
and the intensity of the final colour is proportional to the 
concentration of antibody present in the sample.
A list of assays that are validated on the PhDTM system is 
available from BioRad (www.bio-rad.com; PhD™ Validated 
Assay List).
Results
Analyses with ELISA kits from the BioRad list produced valid 
results in our laboratory and these methods were automated 
without any problems. However, when performing the non-
validated MK016 assay on the PhDTM system, the calibrators 
did not produce the required OD values recommended by 
the quality control sheet included in the kit (Figure 1).
The highest calibrator reached an OD of only 1.417 ± 0.245 
(range 1.252 –1.813) instead of 2.500 as specified on the 
quality control certificate. Although the lower calibrators 
were associated with smaller margins of error, they showed 
a similar trend. All results calculated from this calibration 
curve were therefore too low and hence invalid.
Comparison of the individual steps of the automated and 
manual methods identified a difference of 10 minutes in all 
incubation periods. The PhD™ system times incubation for 
each well individually and proceeds to the next step only once 
the exact incubation time has been reached for that specific 
well. However, timing of manual assays usually starts only 
after reagents have been added to the last well of the plate; 
i.e. well incubation is timed rather than plate incubation.
In an effort to address this difference, all incubation steps 
were increased from 30 minutes to 40 minutes on the PhD™ 
system. The duration of the washing steps of the two methods 
was very similar and therefore not regarded as contributing 
to the discrepant results. The duration of the washing steps 
was therefore left unchanged.
A total of 16 calibration curves were subsequently 
generated from the PhD™ system to validate the adjusted 
protocol. All the OD values obtained produced acceptable 
calibration curves (Figure 2) and the mean OD value for the 
highest calibrator reached 2.295 ± 0.171 (median = 2.405; 
range = 1.934–2.553). The recommended values for the high 
and low controls are 2.4 mg/L – 3.6 mg/L and < 0.35 mg/L, 
respectively. The high and low controls as used on the 
PhD™ system produced results of 2.538 ± 0.094 mg/L and 
< 0.35 mg/L, respectively.
To confirm our findings, calibrators and controls were 
included in different positions and orders on the plate. 
Values obtained for these tests were within 5% of the 
required ranges, which suggested that the amended protocol 
had a uniform effect on all individual wells of the plate (data 
not shown).
Discussion
Automated systems, such as the BioRad PhD™ instrument, 
are extremely useful and accurate in assessing immune 
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FIGURE 1: VaccZyme™ Anti-Hib Enzyme-linked immunosorbent assays 
calibration curve as provided on the quality control sheet.9
FIGURE 2: VaccZyme™ Anti-Hib enzyme-linked immunosorbent assay calibration 
curves before and after optimisation.
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responses to specific antigens following disease or vaccination. 
The major advantages of automation or semi-automation 
include the use of volumes as low as 1 mL, increased accuracy 
and reproducibility of results, better use of expensive 
skilled labour, faster overall laboratory turnaround time, 
ability to perform multiple assays simultaneously and cost 
effectiveness due to use of multianalyte reagents. Use of an 
automated system also eliminates pipette volume variation 
and handling errors.
Accurate, reproducible and reliable laboratory results are 
crucial for patient management and care, such as initiating 
treatment in patients with possible immunodeficiency and 
revaccination of children with insufficient protection following 
routine childhood vaccination. It is furthermore important for 
evaluation of study cohort results or establishing reference 
ranges for specific populations or age groups.
This study emphasises the importance of optimisation and 
validation whenever changing protocols or reagents in order 
to produce valid and accurate results. In the case of the MK016 
assay it was not possible to transfer the protocol established 
for the manual method to the automated system without 
modification. After troubleshooting all the individual steps 
of both methods, a methodological difference was identified 
and addressed. The modified protocol was scrutinised by 
repeated measurements of samples of known concentration 
in different assays and plate positions before amending the 
existing protocol.
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